# Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)

> **NCT00371592** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 50 (estimated)

## Conditions studied

- HIV Infections
- Herpesvirus 2, Human

## Interventions

- **DRUG:** Acyclovir
- **DRUG:** Acyclovir placebo

## Key facts

- **NCT ID:** NCT00371592
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2013-09-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00371592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00371592, "Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00371592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*